- Home
- DNTH vs PHK Comparison
DNTH vs PHK Comparison
Compare DNTH & PHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- PHK
- Stock Information
- Founded
- DNTH 2015
- PHK 2003
- Country
- DNTH United States
- PHK United States
- Employees
- DNTH N/A
- PHK N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- PHK Finance/Investors Services
- Sector
- DNTH Health Care
- PHK Finance
- Exchange
- DNTH Nasdaq
- PHK Nasdaq
- Market Cap
- DNTH 670.7M
- PHK 777.7M
- IPO Year
- DNTH N/A
- PHK N/A
- Fundamental
- Price
- DNTH $22.29
- PHK $4.94
- Analyst Decision
- DNTH Strong Buy
- PHK
- Analyst Count
- DNTH 9
- PHK 0
- Target Price
- DNTH $46.43
- PHK N/A
- AVG Volume (30 Days)
- DNTH 245.5K
- PHK 491.5K
- Earning Date
- DNTH 03-20-2025
- PHK 01-01-0001
- Dividend Yield
- DNTH N/A
- PHK 12.61%
- EPS Growth
- DNTH N/A
- PHK N/A
- EPS
- DNTH N/A
- PHK N/A
- Revenue
- DNTH $5,366,000.00
- PHK N/A
- Revenue This Year
- DNTH $100.14
- PHK N/A
- Revenue Next Year
- DNTH N/A
- PHK N/A
- P/E Ratio
- DNTH N/A
- PHK N/A
- Revenue Growth
- DNTH 51.41
- PHK N/A
- 52 Week Low
- DNTH $18.35
- PHK $4.13
- 52 Week High
- DNTH $33.77
- PHK $5.15
- Technical
- Relative Strength Index (RSI)
- DNTH 49.77
- PHK 48.43
- Support Level
- DNTH $21.28
- PHK $4.91
- Resistance Level
- DNTH $23.28
- PHK $4.96
- Average True Range (ATR)
- DNTH 1.75
- PHK 0.04
- MACD
- DNTH 0.17
- PHK 0.01
- Stochastic Oscillator
- DNTH 79.92
- PHK 59.09
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About PHK Pimco High Income Fund
PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. Its secondary objective is to seek capital appreciation.